MedTrace Logo

Brain Hippocampal Volume Relationship With Anxious Symptoms in Major Depressive Patients

NCT04430556 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-06-12

No results posted yet for this study

Summary

The objective of this transversal study is to determine if there is a difference in the volume of the hippocampus with the degree of anxiety.

Conditions

Interventions

DRUG

Sertraline

Sertraline will be started in all patients, unless it is contraindicated, in this case, Escitalopram will be indicated.

Sponsors & Collaborators

  • Instituto de Información e Investigación en Salud Mental A. C.

    collaborator UNKNOWN

  • Hospital Universitario Dr. Jose E. Gonzalez

    lead OTHER

Principal Investigators

  • Jose A Ontiveros Sanchez de la Barquera, MD, PhD · Hospital Universitario Dr. Jose E. Gonzalez

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04430556 on ClinicalTrials.gov